ACT-1004-1239

Modify Date: 2024-01-21 21:52:36

Use of ACT-1004-1239

ACT-1004-1239 is a potent, selective, orally available CXCR7 antagonist with an IC50 value of 3.2 nM.

Name	ACT-1004-1239

Description	ACT-1004-1239 is a potent, selective, orally available CXCR7 antagonist with an IC50 value of 3.2 nM.
Related Catalog	Research Areas >> Cancer Signaling Pathways >> GPCR/G Protein >> CXCR Research Areas >> Inflammation/Immunology Signaling Pathways >> Immunology/Inflammation >> CXCR Research Areas >> Neurological Disease
References	[1]. Richard-Bildstein S, et al. Discovery of the Potent, Selective, Orally Available CXCR7 Antagonist ACT-1004-1239. J Med Chem. 2020 Dec 24;63(24):15864-15882.

Molecular Formula	C₂₇H₂₈F₂N₆O₃
Molecular Weight	522.55

Get all suppliers and price by the below link: